Advertisement
Merck & Co., Inc.

Merck & Co., Inc. (MRK) Stock Overview

Explore Merck & Co., Inc.’s financial performance, market position, analyst ratings, and future outlook.

MRKNYSE
HealthcareDrug Manufacturers - General
$119.05
$1.71(1.42%)
U.S. Market opens in 64h 23m
Advertisement

Merck & Co., Inc. (MRK)

Meyka AI Score

Z

Key Financials

Market Cap294B
P/E Ratio32.95
EPS (TTM)$3.55
ROE0.18%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year TargetN/A

MRK Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Merck & Co., Inc. (MRK) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of F, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 55.47, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of N/A.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 32.95 and a market capitalization of 294B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-1.42%
5-Day Change
-1.57%
1-Month Change
5.94%
3-Month Change
2.70%
6-Month Change
18.68%
Year-to-Date (YTD) Change
13.09%
1-Year Change
45.49%
3-Year Change
8.36%
5-Year Change
57.77%
All-Time (Max) Change
30008.51%

Contact Information

908 740 4000
126 East Lincoln Avenue, Rahway, NJ, 07065

Company Facts

730,000 Employees
IPO DateJan 13, 1978
CountryUS
Actively Trading

Frequently Asked Questions